Viking Therapeutics (Warrant)

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch VKTXW and buy or sell other stocks, ETFs, and their options commission-free!

About VKTXW

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. 

CEO
Brian Lian, PhD, MBA
CEOBrian Lian, PhD, MBA
Employees
Employees
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2012
Founded2012
Employees
Employees

VKTXW Key Statistics

Market cap
Market cap
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
Average volume
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
52 Week high
52 Week low
52 Week low

VKTXW News

Nasdaq 3d
Viking Therapeutics, Inc. Suffers a Larger Drop Than the General Market: Key Insights

In the latest close session, Viking Therapeutics, Inc. (VKTX) was down 4.23% at $32.80. The stock trailed the S&P 500, which registered a daily loss of 0.41%. M...

Viking Therapeutics, Inc. Suffers a Larger Drop Than the General Market: Key Insights
Nasdaq 5d
Viking Therapeutics Gears Up for Q1 Earnings: Here's What to Expect

We expect investors to focus on updates related to Viking Therapeutics’ VKTX pipeline when it reports first-quarter 2026 earnings. In the last reported quarter,...

Viking Therapeutics Gears Up for Q1 Earnings: Here's What to Expect

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.